Refocus Group, Inc. is a medical device company engaged in the research and development of treatments for human vision disorders. Our mission is to become the surgical standard of care for presbyopia. Refocus Group's latest product is the VisAbility™ Implant System, which is used in an innovative procedure known as the VisAbility™ Procedure. The implant is an investigational device and is not yet approved for sale or use in the United States or Canada. However, the product is currently approved for sale in the European Union.
View Top Employees from Refocus Group, Inc.| Website | http://www.refocus-group.com |
| Revenue | $5 million |
| Funding | $15 million |
| Employees | 11 (11 on RocketReach) |
| Phone | (877) 368-0200 |
| Technologies |
JavaScript,
PHP,
Nginx
+13 more
(view full list)
|
| Industry | Medical Practice, Medical Devices & Equipment, Medical Devices, Manufacturing, Marketing and Advertising, Maritime |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 33 Companies |
Looking for a particular Refocus Group, Inc. employee's phone or email?
Refocus Group, Inc. Questions
The Refocus Group, Inc. annual revenue was $5 million in 2023.
Steve Shapu is the Director of Finance of Refocus Group, Inc..
11 people are employed at Refocus Group, Inc..
Refocus Group, Inc. is based in Dallas, Texas.
The NAICS codes for Refocus Group, Inc. are [54, 541, 33].
The SIC codes for Refocus Group, Inc. are [38, 384].
Top Refocus Group, Inc. Employees
-
25
-
11
-
3
-
22
-
ViewSelene Burke
Optometrist and Vice President of Clinical Affairs at Refocus Group, Inc.
Plano, Texas, United States31 -
3
-
1
Related Companies
